Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-Label Treatment Extension Study

ClinicalTrials.gov ID: NCT02896296

Public ClinicalTrials.gov record NCT02896296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Depot Buprenorphine (RBP-6000) Treatment Extension Study in Subjects With Opioid Use Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study is to provide ongoing treatment with RBP-6000 and safety monitoring for subjects who complete the RB-US-13-0003 study (NCT02510014) and for whom a new treatment venue has not been identified or arranged.

Study identification

NCT ID
NCT02896296
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Indivior Inc.
Industry
Enrollment
208 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 16, 2016
Primary completion
Aug 22, 2017
Completion
Aug 22, 2017
Last update posted
Nov 28, 2018

2016 – 2017

United States locations

U.S. sites
29
U.S. states
17
U.S. cities
28
Facility City State ZIP Site status
Boyett Health Services Hamilton Alabama 35570
Woodland International Research Group Little Rock Arkansas 72211
Collaborative Neuroscience Network Long Beach California 90806
Pacific Research Partners Oakland California 94612
Sarkis Clinical Trials Gainesville Florida 32607
Amit Vijapura Jacksonville Florida 32256
Meridien Research Lakeland Florida 33805
Innovative Clinical Research Lauderhill Florida 33319
Scientific Clinical Research North Miami Florida 33161
Phoenix Medical Research Prairie Village Kansas 66206
Louisiana Research Associates New Orleans Louisiana 70114
Louisiana Clinical Research Shreveport Louisiana 71101
Stanley Street Treatment and Resources Fall River Massachusetts 02720
Adams Clinical Trials Watertown Massachusetts 02472
Precise Research Centers, Inc. Flowood Mississippi 39232
St Louis Clinical Trials St Louis Missouri 63141
Altea Research Las Vegas Nevada 89102
Hassman Research Institute Berlin New Jersey 08009
Center for Emotional Fitness Cherry Hill New Jersey 08002
Neuro-behavioral Clinical Research Canton Ohio 44708
Midwest Clinical Research Center Dayton Ohio 45417
Rakesh Ranjan MD & Associates, Inc. Garfield Heights Ohio 44125
Pahl Pharmaceutical Professionals Oklahoma City Oklahoma 73112
SP Research, PLLC Oklahoma City Oklahoma 73112
CODA Portland Oregon 97232
Keystone Clinical Solutions Altoona Pennsylvania 16601
Carolina Clinical Trials Charleston South Carolina 29407
Pillar Clinical Research Dallas Texas 75243
InSite Clinical Research DeSoto Texas 75115

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02896296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2018 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02896296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →